Risk of relapse after anti-TNF discontinuation in Inflammatory Bowel Disease: A meta-analysis

被引:0
|
作者
Gisbert, J. P.
Marin, A. C.
Chaparro, M.
机构
[1] Hosp Univ La Princesa, IIS IP, Madrid, Spain
[2] CIBERehd, Gastroenterol Unit, Madrid, Spain
来源
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
P472
引用
收藏
页码:S315 / S315
页数:1
相关论文
共 50 条
  • [1] The Risk of Relapse after Anti-TNF Discontinuation in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis
    Gisbert, Javier P.
    Marin, Alicia C.
    Chaparro, Maria
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 (05): : 632 - 647
  • [2] Risk of Relapse After Anti-TNF Discontinuation in Inflammatory Bowel Disease: A Meta-Analisys
    Gisbert, Javier P.
    Marin, Alicia C.
    Chaparro, Maria
    [J]. GASTROENTEROLOGY, 2015, 148 (04) : S262 - S262
  • [3] Long term risk of relapse after anti-TNF discontinuation based on mucosal healing in inflammatory bowel disease
    Garcia Ortiz, J. M.
    Saenz Gallo, M.
    Trigo Salado, C.
    De La Cruz Ramirez, M. D.
    Marquez Galan, J. L.
    Herrera Justiniano, J. M.
    Bozada Garcia, J. M.
    Leo Carnerero, E.
    [J]. JOURNAL OF CROHNS & COLITIS, 2017, 11 : S404 - S404
  • [4] OUTCOMES FOLLOWING ANTI-TNF DISCONTINUATION AND THE RISK OF RELAPSE IN INFLAMMATORY BOWEL DISEASE; A SINGLE CENTRE EXPERIENCE
    Coffey, L.
    Mullen, A.
    Leyden, J.
    MacMathuna, P.
    [J]. GUT, 2017, 66 : A2 - A2
  • [5] Systematic review: factors associated with relapse of inflammatory bowel disease after discontinuation of anti-TNF therapy
    Gisbert, J. P.
    Marin, A. C.
    Chaparro, M.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 42 (04) : 391 - 405
  • [6] Long-term clinical outcomes after the discontinuation of anti-TNF agents in patients with inflammatory bowel disease: a meta-analysis
    Dai, Cong
    Wang, Yi-Nuo
    Tian, Wen-Ning
    Huang, Yu-Hong
    Jiang, Min
    [J]. REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2023, 115 (10) : 559 - 566
  • [7] Relapse after withdrawal from anti-TNF therapy for inflammatory bowel disease
    Helwig, Ulf
    [J]. ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2017, 55 (01): : 85 - 85
  • [8] Relapse after withdrawal from anti-TNF therapy for inflammatory bowel disease: an observational study, plus systematic review and meta-analysis
    Ahmad, Tariq
    Basavaraju, Umesh
    Basquill, Catriona
    Cameron, Fiona L.
    Christodoulou, Christos
    Cummings, Fraser
    Ding, Nik S.
    Fadra, Adam S.
    Flanders, Lucy
    Gaya, Daniel R.
    Gooding, Ian
    Gordon, John
    Grieveson, Kay
    Harris, Richard
    Hart, Ailsa
    Hendy, Philip
    Irving, Peter
    Johnston, Emma L.
    Johnston, Matthew
    Kennedy, Nicholas A.
    Lal, Simon
    Lamb, Christopher A.
    Lees, Charlie W.
    Lindsay, James O.
    Lithgo, Karen
    Lockett, Melanie
    Maggs, Daniel
    Mann, Steve
    Mansfield, John
    Mason, Joy
    McCartney, Sara
    Murray, Charles D.
    Nowell, Emma
    Parkes, Miles
    Russell, Richard K.
    Satsangi, Jack
    Singh, Abhey
    Stansfield, Catherine
    Thomson, John
    Warner, Ben
    Wilson, David C.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 43 (08) : 910 - 923
  • [9] Anti-TNF Withdrawal in Inflammatory Bowel Disease With Endoscopic Healing and the Risk of Relapse - Reply
    Mahmoud, Remi
    Savelkoul, Edo H. J.
    Jharap, Bindia
    Oldenburg, Bas
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (07) : 1967 - 1968
  • [10] Changes in Anthropometric Parameters After Anti-TNFα Therapy in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis
    Faizan Mazhar
    Vera Battini
    Marco Pozzi
    Elena Invernizzi
    Giulia Mosini
    Michele Gringeri
    Annalisa Capuano
    Cristina Scavone
    Sonia Radice
    Emilio Clementi
    Carla Carnovale
    [J]. BioDrugs, 2020, 34 : 649 - 668